The worst of the coronavirus pandemic may be in the past, but it showed just how badly a fast-spreading infectious disease could affect the world. Most countries were woefully unprepared to deal with a medical event of that magnitude, and for the most part, the world still isn’t equipped to deal with such a pandemic.
Millions of lives were lost worldwide during the pandemic, and to this day thousands of people across the world are still dealing with long Covid symptoms. Researchers recently discussed the possibility of using machine learning and artificial intelligence to prevent future disease outbreaks and pandemics.
Published in the “Science” journal, the review covered the challenges involved in predicting and preventing infectious disease outbreaks and the future role that artificial intelligence could play. The study noted that infectious diseases still present a global challenge that our advancements in pharmaceuticals, molecular genetics and computing power haven’t been able to address.
Infectious diseases such as ebola, Zika, Marburg virus and H5N1 influenza have the potential to cripple the global economy and, even more significantly, take countless lives if they get out of hand. Furthermore, dangerous pathogens such as multidrug-resistant tuberculosis and carbapenem-resistant Enterobacteriaceae (CRE) present a constant risk of widespread disease outbreaks.
As the world becomes even more interconnected, it is crucial that we develop ways of preventing infectious disease outbreaks before they spread across borders and cause immense stress on already-stretched healthcare systems. Leveraging increasingly advancing software could give us the tools we need to detect infectious diseases as early as possible and deploy preventative and treatment options before they proliferate.
Machine learning (ML) and artificial intelligence (AI) present the most attractive options as they allow for the study and analysis of gargantuan data sets. ML is already being used to train computers to make more accurate predictions and has aided in searches of small-molecule databases.
Using tools such as machine learning makes it possible for scientists and physicians to examine genetic information in the greatest detail to predict antigens and discover crucial molecular structures that control immune responses and interactions between pathogens and hosts.
Aside from their predictive features, AI and ML can also help in the development of infectious disease treatments. For instance, systems such as NVIDIA’s BioNeMo and GPT-4 can aid in our understanding of fundamental chemical and biological dynamics by combining various scientific data streams.
Although AI and ML are still relatively new fields, they have already played a major role in modernizing medicine and improving treatment outcomes. The technology will most likely be as useful in developing preventative and treatment strategies for infectious diseases.
In the meantime, companies such as BiondVax Therapeutics Ltd. (NASDAQ: BVXV) are working to bring to market immunotherapies targeting infectious diseases so that their outbreaks affect as few people as possible.
NOTE TO INVESTORS: The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom at https://ibn.fm/BVXV
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Approximately 20% of people in the U.S. live in a rural area, and they face…
On October 15, NETEC (National Emerging Special Pathogens Training & Education Center) announced a grant…
Patients are overwhelmed when they are diagnosed with glioblastoma, the most deadly primary brain cancer.…
Thermostable vaccine technology is considered a significant unmet need in epidemic preparedness. Soligenix has been…
Many existing cancer treatments, such as chemotherapy and radiation, don’t distinguish between cancer cells and…
A study whose findings were recently published has provided insights into the cost of treating…